Tumor necrosis factor-α enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via VCAM-1/VLA-4 pathway

Experimental Cell Research

Volumn 318, Issue 14, 2012, Pages 1707-1715

  Song, Kai ^a   Zhu, Fei ^a   Zhang, Han zhong ^a   Shang, Zheng jun ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cell fusion; Oral squamous carcinoma; Tumor necrosis factor ; VCAM 1; VLA 4

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; BLOOD; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL FUSION; COCULTURE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; METASTASIS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SQUAMOUS CELL CARCINOMA; TUMOR MICROENVIRONMENT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

MURINAE;

EID: 84862885863     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.05.022     Document Type: Article

References (35)

1. Hillen F., Griffioen A.W. Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007, 26:489-502.
2. Garofalo A., Chirivi R.G., Foglieni C., Pigott R., Mortarini R., Martin-Padura I., Anichini A., Gearing A.J., Sanchez-Madrid F., Dejana E., et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res. 1995, 55:414-419.
3. Mortensen K., Lichtenberg J., Thomsen P.D., Larsson L.I. Spontaneous fusion between cancer cells and endothelial cells. Cell. Mol. Life Sci. 2004, 61:2125-2131.
4. Singec I., Snyder E.Y. Inflammation as a matchmaker: revisiting cell fusion. Nat. Cell Biol. 2008, 10:503-505.
5. Nygren J.M., Liuba K., Breitbach M., Stott S., Thoren L., Roell W., Geisen C., Sasse P., Kirik D., Bjorklund A., Nerlov C., Fleischmann B.K., Jovinge S., Jacobsen S.E. Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat. Cell Biol. 2008, 10:584-592.
6. Brouckaert P.G., Leroux-Roels G.G., Guisez Y., Tavernier J., Fiers W. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma. Int. J. Cancer 1986, 38:763-769.
7. Watanabe N., Niitsu Y., Umeno H., Sone H., Neda H., Yamauchi N., Maeda M., Urushizaki I. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Cancer Res. 1988, 48:650-653.
8. Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006, 25:409-416.
9. Sethi G., Sung B., Aggarwal B.B. TNF: a master switch for inflammation to cancer. Front. Biosci. 2008, 13:5094-5107.
10. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
11. Balkwill F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 2009, 9:361-371.
12. Kobayashi H., Boelte K.C., Lin P.C. Endothelial cell adhesion molecules and cancer progression. Curr. Med. Chem. 2007, 14:377-386.
13. Choe N., Zhang J., Iwagaki A., Tanaka S., Hemenway D.R., Kagan E. Asbestos exposure upregulates the adhesion of pleural leukocytes to pleural mesothelial cells via VCAM-1. Am. J. Physiol. 1999, 277:L292-L300.
14. DiVietro J.A., Brown D.C., Sklar L.A., Larson R.S., Lawrence M.B. Immobilized stromal cell-derived factor-1alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion. J. Immunol. 2007, 178:3903-3911.
15. Cannistra S.A., Ottensmeier C., Tidy J., DeFranzo B. Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp. Hematol. 1994, 22:996-1002.
16. Langley R.R., Carlisle R., Ma L., Specian R.D., Gerritsen M.E., Granger D.N. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirc. 2001, 8:335-345.
17. Michigami T., Shimizu N., Williams P.J., Niewolna M., Dallas S.L., Mundy G.R., Yoneda T. Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. Blood 2000, 96:1953-1960.
18. Slack-Davis J.K., Atkins K.A., Harrer C., Hershey E.D., Conaway M. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res. 2009, 69:1469-1476.
19. Mattila P., Majuri M.L., Renkonen R. VLA-4 integrin on sarcoma cell lines recognizes endothelial VCAM-1. Differential regulation of the VLA-4 avidity on various sarcoma cell lines. Int. J. Cancer 1992, 52:918-923.
20. Martin-Padura I., Mortarini R., Lauri D., Bernasconi S., Sanchez-Madrid F., Parmiani G., Mantovani A., Anichini A., Dejana E. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res. 1991, 51:2239-2241.
21. Pawelek J.M. Cancer-cell fusion with migratory bone-marrow-derived cells as an explanation for metastasis: new therapeutic paradigms. Future Oncol. 2008, 4:449-452.
22. Rachkovsky M., Sodi S., Chakraborty A., Avissar Y., Bolognia J., McNiff J.M., Platt J., Bermudes D., Pawelek J. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin. Exp. Metastasis 1998, 16:299-312.
23. Lu X., Kang Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9385-9390.
24. Miller F.R., Mohamed A.N., McEachern D. Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res. 1989, 49:4316-4321.
25. Duelli D.M., Lazebnik Y.A. Primary cells suppress oncogene-dependent apoptosis. Nat. Cell Biol. 2000, 2:859-862.
26. Johansson C.B., Youssef S., Koleckar K., Holbrook C., Doyonnas R., Corbel S.Y., Steinman L., Rossi F.M., Blau H.M. Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat. Cell Biol. 2008, 10:575-583.
27. Wu Y., Zhou B.P. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer 2010, 102:639-644.
28. Rebhun R.B., Cheng H., Gershenwald J.E., Fan D., Fidler I.J., Langley R.R. Constitutive expression of the alpha4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma. Neoplasia 2010, 12:173-182.
29. Liang S., Dong C. Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions. Am. J. Physiol. Cell Physiol. 2008, 295:C701-C707.
30. Klemke M., Weschenfelder T., Konstandin M.H., Samstag Y. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J. Cell Physiol. 2007, 212:368-374.
31. Okahara H., Yagita H., Miyake K., Okumura K. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res. 1994, 54:3233-3236.
32. Wu T.C. The role of vascular cell adhesion molecule-1 in tumor immune evasion. Cancer Res. 2007, 67:6003-6006.
33. Li H., Ge C., Zhao F., Yan M., Hu C., Jia D., Tian H., Zhu M., Chen T., Jiang G., Xie H., Cui Y., Gu J., Tu H., He X., Yao M., Liu Y., Li J. HIF-1alpha-activated ANGPTL4 contributes to tumor metastasis via VCAM-1/integrin beta1 signaling in human hepatocellular carcinoma. Hepatology 2011.
34. Zhang S., Shpall E., Willerson J.T., Yeh E.T. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ. Res. 2007, 100:693-702.
35. Bjerregaard B., Holck S., Christensen I.J., Larsson L.I. Syncytin is involved in breast cancer-endothelial cell fusions. Cell. Mol. Life Sci. 2006, 63:1906-1911.